{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:51:05Z","timestamp":1767066665729,"version":"3.48.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04300-4","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:45:37Z","timestamp":1767019537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PAX5 expression and its diagnostic utility in gastroenteropancreatic neuroendocrine neoplasm"],"prefix":"10.1186","volume":"25","author":[{"given":"Kun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"1","key":"4300_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","volume":"40","author":"B Lawrence","year":"2011","unstructured":"Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40(1):1\u2013vii. https:\/\/doi.org\/10.1016\/j.ecl.2010.12.005.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"4300_CR2","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1530\/ERC-13-0125","volume":"21","author":"M Fraenkel","year":"2014","unstructured":"Fraenkel M, Kim M, Faggiano A, de Herder WW, Valk GD, Knowledge NET. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocrine-related Cancer. 2014;21(3):R153\u201363. https:\/\/doi.org\/10.1530\/ERC-13-0125.","journal-title":"Endocrine-related Cancer"},{"issue":"1","key":"4300_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41571-022-00696-0","volume":"20","author":"K Kawasaki","year":"2023","unstructured":"Kawasaki K, Rekhtman N, Quintanal-Villalonga \u00c1, Rudin CM. Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies. Nat Rev Clin Oncol. 2023;20(1):16\u201332. https:\/\/doi.org\/10.1038\/s41571-022-00696-0.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"4300_CR4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1097\/PAS.0000000000000916","volume":"41","author":"LM Rooper","year":"2017","unstructured":"Rooper LM, Sharma R, Li QK, Illei PB, Westra WH. INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity. Am J Surg Pathol. 2017;41(11):1561\u20139. https:\/\/doi.org\/10.1097\/PAS.0000000000000916.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4300_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13099","volume":"34","author":"R Taboada","year":"2022","unstructured":"Taboada R, Claro L, Felismino T, de Jesus VH, Barros M, Riechelmann RP. Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasms. J Neuroendocrinol. 2022;34(4):e13099. https:\/\/doi.org\/10.1111\/jne.13099.","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"4300_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00428-021-03202-6","volume":"480","author":"A Kasajima","year":"2022","unstructured":"Kasajima A, Konukiewitz B, Schlitter AM, Weichert W, Kl\u00f6ppel G. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features. Virchows Arch. 2022;480(2):359\u201368. https:\/\/doi.org\/10.1007\/s00428-021-03202-6.","journal-title":"Virchows Arch"},{"issue":"3","key":"4300_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ecl.2018.05.001","volume":"47","author":"H Sorbye","year":"2018","unstructured":"Sorbye H, Baudin E, Perren A. The problem of High-Grade gastroenteropancreatic neuroendocrine neoplasms: Well-Differentiated neuroendocrine tumors, neuroendocrine carcinomas, and beyond. Endocrinol Metab Clin North Am. 2018;47(3):683\u201398. https:\/\/doi.org\/10.1016\/j.ecl.2018.05.001.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"4300_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/modpathol.2016.217","volume":"30","author":"B Konukiewitz","year":"2017","unstructured":"Konukiewitz B, Schlitter AM, Jesinghaus M, Pfister D, Steiger K, Segler A, et al. Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20. Mod Pathology: Official J United States Can Acad Pathol Inc. 2017;30(4):587\u201398. https:\/\/doi.org\/10.1038\/modpathol.2016.217.","journal-title":"Mod Pathology: Official J United States Can Acad Pathol Inc"},{"issue":"6","key":"4300_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/jcp.2006.039917","volume":"60","author":"P Mhawech-Fauceglia","year":"2007","unstructured":"Mhawech-Fauceglia P, Saxena R, Zhang S, Terracciano L, Sauter G, Chadhuri A, et al. Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis. J Clin Pathol. 2007;60(6):709\u201314. https:\/\/doi.org\/10.1136\/jcp.2006.039917.","journal-title":"J Clin Pathol"},{"issue":"4","key":"4300_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1309\/8J2PQHF603WHVL8K","volume":"129","author":"G Sica","year":"2008","unstructured":"Sica G, Vazquez MF, Altorki N, Port J, Lee PC, Liu Y, Hyjek E, Saqi A. PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens. Am J Clin Pathol. 2008;129(4):556\u201362. https:\/\/doi.org\/10.1309\/8J2PQHF603WHVL8K.","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"4300_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/PAI.0000000000000473","volume":"26","author":"S Ainechi","year":"2018","unstructured":"Ainechi S, Mann SA, Lin J, Patil D, Sheehan CE, Yang Z, et al. Paired box 5 (PAX5) expression in poorly differentiated neuroendocrine carcinoma of the gastrointestinal and pancreatobiliary tract: diagnostic and potentially therapeutic implications. Appl Immunohistochem Mol Morphology: AIMM. 2018;26(8):545\u201351. https:\/\/doi.org\/10.1097\/PAI.0000000000000473.","journal-title":"Appl Immunohistochem Mol Morphology: AIMM"},{"issue":"3","key":"4300_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00428-022-03346-z","volume":"481","author":"C Pryma","year":"2022","unstructured":"Pryma C, Villamil C, Gibb EA, Oo HZ, Seiler R, Contreras-Sanz A, et al. Uroplakin II as a single marker for luminal versus basal molecular subtypes in muscle invasive urothelial carcinoma. Virchows Archiv: Int J Pathol. 2022;481(3):397\u2013403. https:\/\/doi.org\/10.1007\/s00428-022-03346-z.","journal-title":"Virchows Archiv: Int J Pathol"},{"issue":"5","key":"4300_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/PAS.0b013e318191614f","volume":"33","author":"LM Sullivan","year":"2009","unstructured":"Sullivan LM, Atkins KA, LeGallo RD. PAX immunoreactivity identifies alveolar rhabdomyosarcoma. Am J Surg Pathol. 2009;33(5):775\u201380. https:\/\/doi.org\/10.1097\/PAS.0b013e318191614f.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4300_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA, WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138. https:\/\/doi.org\/10.1111\/his.13975.","journal-title":"Histopathology"},{"issue":"2","key":"4300_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.soc.2019.11.003","volume":"29","author":"AM Bellizzi","year":"2020","unstructured":"Bellizzi AM. Pathologic considerations in gastroenteropancreatic neuroendocrine tumors. Surg Oncol Clin N Am. 2020;29(2):185\u2013208. https:\/\/doi.org\/10.1016\/j.soc.2019.11.003.","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"4300_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188637","volume":"1876","author":"M Shi","year":"2021","unstructured":"Shi M, Fan Z, Xu J, Yang J, Li Y, Gao C, et al. Gastroenteropancreatic neuroendocrine neoplasms G3: novel insights and unmet needs. Biochimica et Biophysica Acta (BBA). 2021;1876(2):188637. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188637.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"3","key":"4300_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1158\/2159-8290.CD-21-0669","volume":"12","author":"S Yachida","year":"2022","unstructured":"Yachida S, Totoki Y, No\u00eb M, Nakatani Y, Horie M, Kawasaki K, et al. Comprehensive genomic profiling of neuroendocrine carcinomas of the gastrointestinal system. Cancer Discov. 2022;12(3):692\u2013711. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0669.","journal-title":"Cancer Discov"},{"issue":"6","key":"4300_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/PAI.0000000000000635","volume":"27","author":"Z Fu","year":"2019","unstructured":"Fu Z, Zuo C, Sheehan CE, Patil DT, Lin J, Yang Z, et al. Novel finding of paired box 5 (PAX5) cytoplasmic staining in well-differentiated rectal neuroendocrine tumors (carcinoids) and its diagnostic and potentially prognostic utility. Appl Immunohistochem Mol Morphol. 2019;27(6):454\u201360. https:\/\/doi.org\/10.1097\/PAI.0000000000000635.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"4300_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.semcdb.2015.08.014","volume":"44","author":"VR Paix\u00e3o-C\u00f4rtes","year":"2015","unstructured":"Paix\u00e3o-C\u00f4rtes VR, Salzano FM, Bortolini MC. Origins and evolvability of the PAX family. Semin Cell Dev Biol. 2015;44:64\u201374. https:\/\/doi.org\/10.1016\/j.semcdb.2015.08.014.","journal-title":"Semin Cell Dev Biol"},{"key":"4300_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.semcdb.2015.09.015","volume":"44","author":"AH Monsoro-Burq","year":"2015","unstructured":"Monsoro-Burq AH. PAX transcription factors in neural crest development. Semin Cell Dev Biol. 2015;44:87\u201396. https:\/\/doi.org\/10.1016\/j.semcdb.2015.09.015.","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"4300_CR21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41416-021-01501-y","volume":"125","author":"D Chen","year":"2021","unstructured":"Chen D, Bao X, Zhang R, Ding Y, Zhang M, Li B, Zhang H, Li X, Tong Z, Liu L, Zhou X, Wang S, Cheng X, Zheng Y, Ruan J, Fang W, Zhao P. Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma. Br J Cancer. 2021;125(7):994\u20131002. https:\/\/doi.org\/10.1038\/s41416-021-01501-y.","journal-title":"Br J Cancer"},{"issue":"8","key":"4300_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41419-024-06916-y","volume":"15","author":"S Bhattacharya","year":"2024","unstructured":"Bhattacharya S, Harris HL, Islam R, Bodas S, Polavaram N, Mishra J, Das D, Seshacharyulu P, Kalluchi A, Pal A, Kohli M, Lele SM, Muders M, Batra SK, Ghosh PM, Datta K, Rowley MJ, Dutta S. Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers. Cell Death Dis. 2024;15(8):617. https:\/\/doi.org\/10.1038\/s41419-024-06916-y.","journal-title":"Cell Death Dis"},{"issue":"3","key":"4300_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/labinvest.2008.168","volume":"89","author":"R Kanteti","year":"2009","unstructured":"Kanteti R, Nallasura V, Loganathan S, Tretiakova M, Kroll T, Krishnaswamy S, Faoro L, Cagle P, Husain AN, Vokes EE, Lang D, Salgia R. PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription. Lab Invest. 2009;89(3):301\u201314. https:\/\/doi.org\/10.1038\/labinvest.2008.168.","journal-title":"Lab Invest"},{"issue":"11","key":"4300_CR24","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1043\/2009-0664-OAR1.1","volume":"134","author":"J Song","year":"2010","unstructured":"Song J, Li M, Tretiakova M, Salgia R, Cagle PT, Husain AN. Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung. Arch Pathol Lab Med. 2010;134(11):1702\u20135. https:\/\/doi.org\/10.1043\/2009-0664-OAR1.1.","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"4300_CR25","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/PAS.0000000000001526","volume":"44","author":"J Kim","year":"2020","unstructured":"Kim J, Kim JY, Oh EH, Yoo C, Park IJ, Yang DH, et al. Chromogranin A expression in rectal neuroendocrine tumors is associated with more aggressive clinical behavior and a poorer prognosis. Am J Surg Pathol. 2020;44(11):1496\u2013505. https:\/\/doi.org\/10.1097\/PAS.0000000000001526.","journal-title":"Am J Surg Pathol"},{"issue":"24","key":"4300_CR26","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1182\/blood.2022015520","volume":"140","author":"C Syrykh","year":"2022","unstructured":"Syrykh C, Chaouat C, Poullot E, Amara N, Fataccioli V, Parrens M, Traverse-Glehen A, Molina TJ, Xerri L, Martin L, Dubois R, Lacheretz-Szablewski V, Copin MC, Moreau A, Chenard MP, Cabarrou B, Lusque A, Gaulard P, Brousset P, Laurent C. Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French lymphopath network survey. Blood. 2022;140(24):2573\u201383. https:\/\/doi.org\/10.1182\/blood.2022015520.","journal-title":"Blood"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04300-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:02:57Z","timestamp":1767063777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04300-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4300"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04300-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Hunan Provincial People\u2019s Hospital and The first-affiliated hospital of Hunan Normal University. The study was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. As the study was a retrospective design and did not include any potentially identifiable patient data, informed consent was waived by the Ethics Committee of the Hunan Provincial People\u2019s Hospital and The first-affiliated hospital of Hunan Normal University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"870"}}